Advancements in breast cancer mRNA vaccines: Current development and future prospects
Open Access
- 16 December 2025
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1881 (1) , 189515
Abstract
No abstract availableKeywords
This publication has 195 references indexed in Scilit:
- Discovery of Ketal‐Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine DeliveryAdvanced Science, 2024
- PLGA Nanoparticles Coated with Activated Dendritic Cell Membrane Can Prolong Protein Expression and Improve the Efficacy of mRNAAdvanced Therapeutics, 2024
- Modulating Lipid Nanoparticles with Histidinamide‐Conjugated Cholesterol for Improved Intracellular Delivery of mRNAAdvanced Healthcare Materials, 2024
- Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancerCancer Communications, 2023
- Lipid Nanoparticles Optimized for Targeting and Release of Nucleic AcidAdvanced Materials, 2023
- Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic ApproachAdvanced Therapeutics, 2023
- mRNA vaccine in cancer therapy: Current advance and future outlookClinical and Translational Medicine, 2023
- European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006–2020Clinical Pharmacology & Therapeutics, 2023
- Polymer‐Based mRNA Delivery Strategies for Advanced TherapiesAdvanced Healthcare Materials, 2023
- Poly(β‐Amino Esters): Synthesis, Formulations, and Their Biomedical ApplicationsAdvanced Healthcare Materials, 2018